Skip to main content

Table 1 Clinical and laboratory data and treatment of the patient during follow-up

From: A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report

Age, years

6

7

8

9

10

11

12

13

14

Height, cm (percentile)

97(<3)

111(<3)

119 (3)

126 (10)

132 (10)

143 (25)

150 (25–50)

153 (25–50)

155 (25–50)

Weight, kg (percentile) Serum

13(<3)

18 (3)

22 (25)

23 (10)

26 (10)

34 (25–50)

41 (50)

42 (25–50)

45 (25–50)

BUN, mmol/l (1.7–8.3) a

2.42

2.26

3.73

6.45

4.27

5.32

4.93

6.41

13.49

Cr, umol/l (53–106) a

40.9

48.1

44.3

54.4

56.1

59.2

57

70.9

175

Na, mmol/l (136–146) a

136.2

135.3

136.6

145.4

145.9

139.2

145.1

146.1

145

K, mmol/l (3.5–5.5) a

3.78

3.79

3.35

3.64

3.49

3.57

3.12

3.79

2.99

Cl, mmol/l (97–107) a

92.7

93.3

92.3

103.6

99.5

95.1

105.6

103.5

102.3

HCO3, mmol/l (21–29) a Treatment

33.9

30.6

30.6

29.3

26.8

29.7

24.1

30.2

25.4

recombinant human GH, IU/kg/d

0.1

0.1

0.1

0.15

0.15

0.15

  1. BUN blood urea nitrogen, Cr creatinine, Na sodium, K potassium, Cl chloride, HCO3 bicarbonate
  2. aNormal values in parentheses